Yahoo finance

Home > News and Events

AppYea expands its SleepX patent commercialization portfolio with a non-diluting agreement

AppYea expands its SleepX patent commercialization portfolio with a non-diluting agreement. SleepX signed a new commercialization agreement for two new patents. The SleepX PRO solution is designed to diagnose sleep apnea using only a smartphone, with no physical contact.

Leave a Comment

Your email address will not be published. Required fields are marked *